RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

Award Notice Posted

Solicitation number
75A50126C00010
Agency
Awarded
to Kaleo, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75A50126C00010 Federal contract award
Place of performance
Washington, District of Columbia 20024, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded contract 75A50126C00010 to KALEO, INC. on September 28, 2026, for late-stage clinical development, regulatory approval, and procurement of 2-PAM autoinjectors to treat organophosphate poisoning in adult and pediatric populations under Project Bioshield.

The award funds development and regulatory approval of 2-PAM autoinjectors as a drug/device combination product, along with procurement for the Strategic National Stockpile CHEMPACK Program. The award was made under unrestricted competition with no set-aside applied.

Notice text

This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program. 

Awarded contract 75A50126C00010 to KALEO, INC. for 340910795.00 on 2026-09-28.

Notice history

Notice Type Posted
This notice Award Award Notice
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS) Latest solicitation Solicitation
2-PAM Autoinjectors Project Bioshield Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login

GovTribe for Federal Contractors